SMMT
NASDAQStockSummit Therapeutics Inc.
$16.07+0.60 (+3.91%)
52-Week Range
$13.85
$36.70
Key Stats
Market Cap
12.0B
P/E Ratio
—
Dividend Yield
—
Beta
-1.39
Volume
2.0M
Avg Volume
2.1M
Performance
1M
+5.67%
3M
-11.05%
6M
-18.37%
YTD
-11.76%
1Y
-25.64%
3Y
+842.68%
5Y
+141.56%
Price Chart
ETF Exposure
SMMT is held by 88 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SCHX | Schwab U.S. Large-Cap ETF | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.00% |
| ILCB | iShares Morningstar U.S. Equity ETF | 0.00% |
| IWB | iShares Russell 1000 ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| JKD | iShares Morningstar U.S. Equity ETF | 0.00% |
| RECS | Columbia Research Enhanced Core ETF | 0.00% |
| VONE | Vanguard Russell 1000 ETF | 0.00% |
| JHML | John Hancock Investments - Multifactor Large Cap ETF | 0.00% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| V3AM.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| STXG | Strive 1000 Growth ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
PreviousPage 2 of 2
About SMMT ETF Exposure
Summit Therapeutics Inc. (SMMT) is held by 88 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 12.0B, SMMT is a widely held institutional stock. The stock currently trades at $16.07. Investors can gain exposure to SMMT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SMMT, sorted by portfolio weight.